Development of Novel Imipridones with Alkyne- and Triazole-Linked Warheads on the Tricyclic Skeleton, Showing Superior Ability to Eradicate PANC-1 and Fadu Cells Compared to ONC201
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms252313176 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Tamás Czuczi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Organic Chemistry, Eötvös Loránd University (ELTE), Pázmány P. Sétány 1/A, H-1117 Budapest, Hungary. Hauptthemen laut MEDLINE: Triazoles, Antineoplastic Agents, Alkynes. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hungarian Scientific Research Fund, ELTE Thematic Excellence Programme Synth+, Hungarian Ministry for Innovation and Technology and the Lendület (Momentum) Programme of the Hungarian Academy of Sciences.
Abstract (Originalsprache)
Our ongoing research focuses on the development of new imipridone derivatives. We aim to design compounds that can completely and selectively eradicate cancer cells after relatively short treatment. We have synthetized systematically designed novel hybrids and evaluated their antiproliferative activity against PANC-1 and Fadu cell lines. We have also conducted preliminary studies on the mechanism, including colony formation as well as dose–response tests in HEK293T wild-type (WT) and HEK293T CLPP−/− cells. Following gradual structural fine-tuning based on high throughput screening, we identified two imipridone hybrids as the most potent derivatives. Their unique substitution pattern includes N-methylated propargylamine and ferrocenyl/phenyltriazole moieties on the benzyl groups attached to opposite sides of the imipridone core. We found that the compounds with IC50 values similar to those of ONC201 completely eradicated cancer cells at about 4 μM, while ONC201 treatment at even higher concentrations left 30–50% of viable cells behind. Both compounds exerted equal activity in WT and CLPP−/− HEK293T cells, indicating a ClpP-independent mechanism. Further development is needed to improve the tumor selectivity of the two potent imipridone derivatives. By preserving tumor cytotoxicity, we aim to generate new drug candidates that evade resistance and can be applied in a sufficiently broad therapeutic window.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Organic Chemistry, Eötvös Loránd University (ELTE), Pázmány P. Sétány 1/A, H-1117 Budapest, Hungary.
- Hevesy György PhD School of Chemistry, Pázmány P. Sétány 1/A, H-1117 Budapest, Hungary.
- Department of Molecular Biology, Semmelweis University, Tűzoltó u. 37-47, H-1094 Budapest, Hungary.
- MTA-ELTE Lendület (Momentum) Ion Mobility Mass Spectrometry Research Group, Institute of Chemistry, ELTE Eötvös Loránd University, Pázmány Péter Sétány 1/A, H-1117 Budapest, Hungary.
ORCID-Profile: József Murányi, István Móra, Bianka Gurbi, Dávid Papp, Gitta Schlosser, Miklós Csala, Antal Csámpai
Förderung
- Hungarian Scientific Research Fund
- ELTE Thematic Excellence Programme Synth+
- Hungarian Ministry for Innovation and Technology and the Lendület (Momentum) Programme of the Hungarian Academy of Sciences
- Hungarian Ministry for Innovation and Technology
- Ministry of Innovation and Technology of Hungary from the National Research, Development and Innovation Fund
Zitieren
APA
Czuczi, T., Murányi, J., Móra, I., Gurbi, B., Varga, A., Papp, D., Schlosser, G., Csala, M., & Csámpai, A. (2024). Development of Novel Imipridones with Alkyne- and Triazole-Linked Warheads on the Tricyclic Skeleton, Showing Superior Ability to Eradicate PANC-1 and Fadu Cells Compared to ONC201. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252313176
Vancouver
Czuczi T, Murányi J, Móra I, Gurbi B, Varga A, Papp D, et al. Development of Novel Imipridones with Alkyne- and Triazole-Linked Warheads on the Tricyclic Skeleton, Showing Superior Ability to Eradicate PANC-1 and Fadu Cells Compared to ONC201. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252313176
BibTeX
@article{Czuczi2024,
author = {Czuczi, Tamás and Murányi, József and Móra, István and Gurbi, Bianka and Varga, Attila and Papp, Dávid and Schlosser, Gitta and Csala, Miklós and Csámpai, Antal},
title = {Development of Novel Imipridones with Alkyne- and Triazole-Linked Warheads on the Tricyclic Skeleton, Showing Superior Ability to Eradicate PANC-1 and Fadu Cells Compared to ONC201},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms252313176}
}
EUVIMED